Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials

INTRODUCTION: Patient-reported outcome (PRO) measures serve to capture vital patient information not otherwise obtained by primary study endpoints. This paper examines how PROs are utilized as endpoints in industry-sponsored metastatic breast cancer clinical trials. METHODS: A search was conducted i...

Descripción completa

Detalles Bibliográficos
Autores principales: Krohe, Meaghan, Hao, Yanni, Lamoureux, Roger E., Galipeau, Nina, Globe, Denise, Foley, Catherine, Mazar, Iyar, Solomon, Jeffrey, Shields, Alan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946584/
https://www.ncbi.nlm.nih.gov/pubmed/27441001
http://dx.doi.org/10.4137/BCBCR.S39385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946584/
https://www.ncbi.nlm.nih.gov/pubmed/27441001
http://dx.doi.org/10.4137/BCBCR.S39385

Ejemplares similares